A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab

The goal of the present study was to record changes in bone mineral density (BMD) and markers of bone turnover in patients with rheumatoid arthritis (RA) who were treated with methotrexate combined (or not combined) with infliximab. Included were 90 patients with RA who required anti-TNF-α therapy w...

Descripción completa

Detalles Bibliográficos
Autores principales: Marotte, Hubert, Pallot-Prades, Beatrice, Grange, Laurent, Gaudin, Philippe, Alexandre, Christian, Miossec, Pierre
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206336/
https://www.ncbi.nlm.nih.gov/pubmed/17597527
http://dx.doi.org/10.1186/ar2219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206336/
https://www.ncbi.nlm.nih.gov/pubmed/17597527
http://dx.doi.org/10.1186/ar2219

Ejemplares similares